Pharmaceutical

Image

U.S. Warts Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Feb 2023
  • Country Level
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

U.S. Warts Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 530.70 Million
Diagram Market Size (Forecast Year) USD 1034.30 Million
Diagram CAGR %

U.S. Warts Treatment Market, By Type (Common Warts (Verruca Vulgaris), Genital Warts, Plantar Warts, Flat Warts, Filiform Warts, Periungual Warts, Others), Treatment (Medication, Therapy, Laser Treatment, Surgery, Cantharidin, Candida Antigen Shots, Acupuncture, Others), Product (Prescription, Over the Counter (OTC)), Dosage Form (Creams, Liquid, Gels, Injectable Solutions, Pads, Tape, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

U.S. Warts Treatment Market Analysis and Size

It has been witnessed that approximately 20% of the population suffer from sexually transmitted infections (STI), and a total of 42.5 million people were infected with HPV in 2018 in the U.S. There are more than 60 types of HPV, some of which tend to cause warts on the skin. Presently, numerous research studies are taking place which is anticipated to create a cutting-edge advantage for different manufacturers to develop new and innovative and advanced warts treatment drugs which are anticipated to provide numerous other opportunities in the warts treatment market.

Data Bridge Market Research analyses a growth rate in the U.S. warts treatment market in the forecast period 2023-2030. The expected CAGR of U.S. warts treatment market is tend to be around 8.70% in the mentioned forecast period. The market value is USD 530.7 million in 2022 and it would grow upto USD 1034.3 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

U.S. Warts Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Common Warts (Verruca Vulgaris), Genital Warts, Plantar Warts, Flat Warts, Filiform Warts, Periungual Warts, Others), Treatment (Medication, Therapy, Laser Treatment, Surgery,  Cantharidin, Candida Antigen Shots, Acupuncture, Others), Product (Prescription, Over the Counter (OTC)), Dosage Form (Creams, Liquid, Gels, Injectable Solutions, Pads, Tape, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Market Players Covered

Bausch Health Companies Inc (Canada), Merck & Co., Inc (U.S.), Taro Pharmaceutical Industries Ltd (Israel), CryoIQ (Sweden), GSK plc (U.K.), BioNTech SE (Germany), Serum Institute of India Pvt. Ltd (India), Fotona (U.S.), Orgenesis Inc (U.S.), Perrigo Company plc (Ireland), CryoSurgery, Inc (U.S.), Bristol-Myers Squibb Company (U.S.), Nielsen Biosciences (U.S.), Verrica Pharmaceuticals (U.S.), Aclaris Therapeutics, Inc (U.S.), Nowarta Biopharma Inc. (U.S.), Novan, Inc. (U.S.), Vaxart (U.S.)

Market Opportunities

  • Increasing Prevalence of Cervical Cancer
  • Increased Research and Development Activities

Market Definition

Warts treatment include salicyclic acid, cryotherapy or cantharidin. Warts are a kind of skin infection that is caused by the human papillomavirus (HPV). This infection causes rough, skin-coloured bumps to form on the skin. This viral infection is contagious. In majority of the cases, warts found on the skin are harmless and can disappear without treatment. Warts treatment aims to destroy the wart, stimulate an immune system response to fight the virus, or both.

U.S. Warts Treatment Market Dynamics

Drivers

The growing prevalence of sexually transmitted infections (STIs) is anticipated to boost the market's growth. Approximately 68 million infections in 2018 (prevalence), and that 1 in 5 people in the U.S. have an STI. There were an estimated 67.6 million prevalent and 26.2 million incident STIs in the U.S. Furthermore, Chlamydia, genital herpes, trichomoniasis, and human papillomavirus comprised 97.6% of all prevalent and 93.1% of all incident STIs. Persons between the age group of 15 to 24 years comprise 18.6% of all prevalent infections; however, they comprise 45.5%  of all incident infections. Hence, these higher number of infections boost the market growth.

  • Availability of Diverse Treatments for Warts

Several market players are primarily involved in launching new treatment platforms that are anticipated to increase the growth of the U.S. warts treatment market during the forecast period 2023-2030. For instance, GenieMD, a global provider of telemedicine services, launched their telemedicine app iVisit in 2019, enabling the diagnosis and treatment of patients for warts treatment through virtual visit with the physician.

Opportunities

  • Increasing Prevalence of Cervical Cancer

The number of cervical cancer rates are more in many underdeveloped countries, where more than 80% of cervical cancer cases are diagnosed. As per the statistics of WHO, cervical cancer is the most prevalent type of malignancy in women and the second top cause of cancer-related death in this region, responsible for over 300,000 fatalities per year. This year, approximately 14,100 women in the U.S. will be diagnosed with invasive cervical cancer. There was around 604,127 women were diagnosed with cervical cancer in 2020. It is expected that 4,280 deaths from this disease will occur in the U.S. this year. This boosts the market growth.

  • Increased Research and Development Activities

Increasing R&D in order to develop treatment for warts treatment is anticipated to increase the growth of the market during the forecast period. For instance, Verrica Pharmaceuticals Inc. and Torii Pharmaceutical Co., Ltd. entered into collaboration and license agreement to develop and commercialize product candidates, including VP-102, for a topical formulation of cantharidin for treating molluscum contagiosum and common warts in Japan in March 21. In October 2019, Novan enhanced its proprietary product pipeline for external genital warts by submitting request for a pre-investigational new drug (IND) application to the US FDA for new product candidate—SB207. Thus, all these developments increase the market growth.

 Restraints/Challenges

  • Lack of Awareness About Warts and their Associated Treatment

Despite the increased prevalence rates of warts, the diagnosis rate and treatment options are still low. The low diagnostic rate of warts is because of the lack of awareness about the infection, which may hinder the warts treatment market growth. For instance, in 2018, the diagnosis rate of warts treatment in U.S. among girls aged 15 to 17 years, was reduced by 92%, compared to 2014. Additionally, existing treatment procedures are often painful and can have unfavorable outcomes such as scarring that often requires frequent visits. This results in a reduction in the diagnostic rate, which is likely to LIMIT the warts treatment market.

This U.S. warts treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the U.S. warts treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

U.S. Warts Treatment Market Scope

The U.S. warts treatment market is segmented on the basis of type, treatment, product, dosage form, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Common Warts (Verruca Vulgaris)
  • Genital Warts
  • Plantar Warts
  • Flat Warts
  • Filiform Warts
  • Periungual Warts
  • Others

Treatment

  • Medication
  • Therapy
  • Laser Treatment
  • Surgery
  • Cantharidin
  • Candida Antigen Shots
  • Acupuncture
  • Others

Product

  • Prescription
  • Over the Counter (OTC)

Dosage Form

  • Creams
  • Liquid
  • Gels
  • Injectable Solutions
  • Pads
  • Tape
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy  

Competitive Landscape and U.S. Warts Treatment Market Share Analysis

The U.S. warts treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to U.S. warts treatment market.

Key players operating in the U.S. warts treatment market include:

  • Bausch Health Companies Inc (Canada)
  • Merck & Co., Inc (U.S.)
  • Taro Pharmaceutical Industries Ltd (Israel)
  • CryoIQ (Sweden)
  • GSK plc (U.K.)
  • BioNTech SE (Germany)
  • Serum Institute of India Pvt. Ltd (India)
  • Fotona (U.S.)
  • Orgenesis Inc (U.S.)
  • Perrigo Company plc (Ireland)
  • CryoSurgery, Inc (U.S.)
  • Bristol-Myers Squibb Company (U.S.)
  • Nielsen Biosciences (U.S.)
  • Verrica Pharmaceuticals (U.S.)
  • Aclaris Therapeutics, Inc (U.S.)
  • Nowarta Biopharma Inc. (U.S.)
  • Novan, Inc. (U.S.)
  • Vaxart (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The U.S. warts treatment market was USD 530.7 million in 2022.
The U.S. warts treatment market is projected to grow at a CAGR of 8.70% during the forecast period of 2023-2030.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials